Qnovia, Inc. announced its CEO is speaking publicly to FDA and NIH at the joint agency public meeting on Advancing Smoking Cessation today at FDA's White Oak Campus. Qnovia is a pharmaceutical company ...
The smoking-cessation drugs on the market don’t work well for the majority of people, and they come with side effects and reputations that keep some smokers from ever trying them. Despite this ...
Aim: To assess potential barriers to clinical integration of tailored smoking cessation treatment among African American and white smokers in the USA. Methods: A total of 392 smokers (203 white ...